A shadow market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Treatment Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these profiles directly for supplier links, while also receiving discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing market exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and assertions of next-day UK delivery. Vendors promote the substance there before directing customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could result in individuals administering substances of uncertain source.
Some experts said the demand for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, risking penalties, legal action or prison.
Service Reaction and Content Removal
According to TikTok, the service has removed problematic material and banned associated hashtags and search suggestions. The company said it was committed to maintaining the platform safe and investing in strengthening compliance measures.
Online Trading Operations
Research also discovered groups with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of members, filled with photos of weight loss, positive testimonials and step-by-step instructions for mixing or administering at residence.
Within minutes of entering one group, a seller shared WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.
Item Details and Pricing
Within these communities, posts display black plastic parcels with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how much time a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for the messaging service said it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering substances they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has previously encountered patients harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may subject patients to possibly significant health risks”.
